Abstract Background Patients on dialysis often suffer from carnitine deficiency due to reduced intake, reduced synthesis in the kidneys, and clearing through dialysis
First, differences in design, individual characteristics, and follow-up duration among the included meta-analyses may contribute to heterogeneity in the results, particularly in the context of patients prior medication history
However, the prescribing provider must establish clear clinical justification, which may include metabolic markers, weight-loss medical history, or genetic predispositions relevant to your case
Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders
Liu C, Liu WH, Yang W, Chen L, Xue Y, Chen XY